A physician at Hematology Oncology of Salem in Oregon, Natasha Tiffany MD engages in management and development at the Salem Cancer Institute, as well as work with Williamette Clinical Research. One area that Dr. Natasha Tiffany focuses on is hematology, which focuses on the blood. Myeloma is a cancer that affects plasma cells, white blood cells that are responsible for producing antibodies that fight infections and diseases within the body. By preventing antibodies from working, myeloma cells contribute to a weakened immune system that is more prone to infection. Individuals who are more at risk of this cancer are typically men, those who are obese, those who have been exposed to radiation, those who have worked in a petroleum-related industry, or those who are over 50 years old. Multiple treatment options can assist with easing bone pain and slowing down the myeloma cells' growth. Your health and stage of myeloma will determine which treatment option may be most effective. The treatments include chemotherapy, anemia drugs, immunomodulators, stem cell transplant, and radiation therapy.
0 Comments
Leave a Reply. |
AuthorNatasha Tiffany, MD, is a physician, educator, and research scientist currently working in Oregon. A Partner and Physician in a private practice located in the state’s capital city of Salem, Dr. Tiffany teaches at her alma mater, Oregon Health & Science University, where she is an Affiliate Assistant Professor in the Hematology and Medical Oncology Division. Archives
October 2019
Categories
All
|